IRF3抑制LPS诱导肝星状细胞LX-2的炎症因子的分泌

详细信息    查看全文 | 推荐本文 |

英文篇名：IRF3 suppress the secretion of inflammatory cytokines in the hepatic stellate cell induced by LPS 作者：刘云洁 ; 程玮 ; 李丽 ; 顾萌 ; 徐涛 英文作者：Liu Yunjie;Cheng Wei;Li Li;Pharmacy Intravenous Admixture Service,The Third Affiliated Hospital of Anhui Medical University,Hefei Binhu Hospital;PLA 92752 Troops Health Team;School of Pharmacy,Anhui Medical University; 关键词：IRF3 ; TNF-α ; 肝星状细胞 ; LX-2细胞 ; 炎症因子 英文关键词：IRF3;;TNF-α;;hepatic stellate cells;;LX-2 cells;;inflammatory factor 中文刊名：YIKE 英文刊名：Acta Universitatis Medicinalis Anhui 机构：安徽医科大学第三附属医院(合肥市滨湖医院)静脉用药调配中心;解放军92752部队卫生队;安徽医科大学药学院; 出版日期：2019-01-11 14:05 出版单位：安徽医科大学学报 年：2019 期：v.54 基金：安徽医科大学博士科研资助项目(编号:XJ201536);; 国家自然科学基金(编号:81700522);; 安徽省自然科学基金面上项目(编号:1808085MH235) 语种：中文; 页：YIKE201902003 页数：5 CN：02 ISSN：34-1065/R 分类号：14-18

摘要

目的研究干扰素调节因子3(IRF3)对LPS诱导的肝星状细胞中LX-2中炎症因子IL-6及TNF-α分泌的影响。方法利用脂质体将质粒pc DNA3-IRF3瞬时转染到人肝星状细胞LX-2中过量表达IRF3,qRT-PCR和Western blot法检测转染效率,并检测炎症因子IL-6及TNF-α的表达。结果qRT-PCR和Western blot结果显示用2μg/ml的LPS刺激LX-2细胞12 h后,与正常组比较,IRF3的表达量明显降低,而诱导产生的炎症因子TNF-α及IL-6的表达量则明显上升。而pc DNA3转入LX-2细胞12 h后,与pc DNA3空载体对照组比较,pc DNA3转染组中炎症因子IL-6及TNF-α表达量在LX-2细胞中被显著抑制。结论在肝星状细胞中,IRF3能够抑制LPS诱导的肝星状细胞LX-2中炎症因子IL-6及TNF-α的表达。
        Objective To investigate the effect of IRF3 on the secretion of inflammatory cytokines IL-6 and TNF-αin hepatic stellate cells induced by LPS. Methods Transient transfection of plasmid pcDNA3-IRF3 into LX-2 of human hepatic stellate cells by liposome was used to detect the transfection efficiency,and the expression of inflammatory factor IL-6 and TNF-α was detected by Western blot and qRT-PCR. Results The results of qRT-PCR and Western blot showed that the expression of TNF-α and IL-6 in LX-2 cells stimulated with 2 μg/ml LPS for 12 h was significantly lower than that in normal control group,while the expression of TNF-α and IL-6 increased significantly. However,after pcDNA3 was transfected into LX-2 cells for 12 h,the expression levels of inflammatory factors IL-6 and TNF-α in pcDNA3 transfected group were significantly inhibited in LX-2 cells compared with the control group. Conclusion IRF3 can inhibit the expression of inflammatory cytokines IL-6 and TNF-α in LX-2 induced by LPS.

引文

[1] Koller T,Kollerova J,Huorka M,et al. Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients[J]. Eur J Gastroenterol Hepatol,2014,26(10):1108-15.
    [2] Fuchs B C,Hoshida Y,Fujii T,et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma[J]. Hepatology,2014,59(4):1577-90.
    [3]付娆,张学荣,廖明,等.以i TRAQ技术分析大鼠肝纤维化发展成肝癌过程中肝组织差异表达的蛋白质[J].世界华人消化杂志,2015,23(12):1873-82.
    [4] Zhu Y,Ni T,Deng W,et al. Effects of NLRP6 on the proliferation and activation of human hepatic stellate cells[J]. Exp Cell Res,2018:[Epub ahead of print].
    [5]王爱秀. TWEAK/Fn14通过激活NF-κB/STAT3信号通路诱导肝星状细胞分泌促炎症因子[D].南京:南京大学,2017.
    [6] Liu L M,Tu W J,Zhu T,et al. IRF3 is an important molecule in the UII/UT system and mediates immune inflammatory injury in acute liver failure[J]. Oncotarget,2016,7(31):49027-41.
    [7] Qiao J T,Cui C,Qing L,et al. Activation of the STING-IRF3pathway promotes hepatocyte inflammation,apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease[J]. Metabolism,2017,81:13-24.
    [8] Loi P,Yuan Q,Torres D,et al. Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury[J]. Hepatology,2013,57(1):351-61.
    [9] Zhao G N,Jiang D S,Li H. Interferon regulatory factors:at the crossroads of immunity,metabolism,and disease[J]. BBA-biomembranes,2015,1852(2):365-78.
    [10]张晓音,吴旻,李雨萌,等.脂多糖的效应及其机理研究进展[J].动物医学进展,2015,36(12):133-6.
    [11]孙雪芳,王洪新,梁灵君,等.黄芪多糖通过TLR4/NF-κB信号通路抑制脂多糖诱导的大鼠心肌细胞肥大[J].中国药理学通报,2013,29(2):208-12.